Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Feldmann

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Analytical Biochemistry|January 26, 2012
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapsesSlava Stamova, Anja Feldmann, Marc Cartellieri, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancersJordi Pfeifer Serrahima, Congcong Zhang, Pranav Oberoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
International Journal of Molecular Sciences|June 10, 2023
Preclinical Characterization of the <sup>177</sup>Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5Franziska Striese, Christin Neuber, Sandy Gräßel, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
Molecular Therapy Oncolytics|May 29, 2020
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive LeukemiaSimon Loff, Josephine Dietrich, Jan-Erik Meyer, et al.
Oncoimmunology|September 14, 2020
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapyAnja Feldmann, Anja Hoffmann, Ralf Bergmann, et al.
Cancers|March 10, 2022
Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal AdenocarcinomaIoana Plesca, Iva Benešová, Carolin Beer, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Analytical Biochemistry|January 26, 2012
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapsesSlava Stamova, Anja Feldmann, Marc Cartellieri, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancersJordi Pfeifer Serrahima, Congcong Zhang, Pranav Oberoi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2011
Retargeting of human regulatory T cells by single-chain bispecific antibodiesStefanie Koristka, Marc Cartellieri, Anke Theil, et al.
Molecular Immunology|October 22, 2011
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker moduleSlava Stamova, Marc Cartellieri, Anja Feldmann, et al.
International Journal of Molecular Sciences|June 10, 2023
Preclinical Characterization of the <sup>177</sup>Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5Franziska Striese, Christin Neuber, Sandy Gräßel, et al.
Oncoimmunology|February 6, 2014
TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunityMarc Cartellieri, Claudia Arndt, Anja Feldmann, et al.
Molecular Therapy Oncolytics|May 29, 2020
Rapidly Switchable Universal CAR-T Cells for Treatment of CD123-Positive LeukemiaSimon Loff, Josephine Dietrich, Jan-Erik Meyer, et al.
Oncoimmunology|September 14, 2020
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapyAnja Feldmann, Anja Hoffmann, Ralf Bergmann, et al.
Cancers|March 10, 2022
Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal AdenocarcinomaIoana Plesca, Iva Benešová, Carolin Beer, et al.
Pageof 9